Clinical Trials Directory

Trials / Completed

CompletedNCT04653506

Paracetamol / Ibuprofen for Postpartum Pain in the Early Postpartum Period

Non - Opioid Treatments (Single Administration) for Pain During the Early Postpartum Period After Vaginal Delivery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The investigators will examine the effectiveness of non-opioid analgesia (Paracetamol versus Ibuprofen) in the early postpartum period

Detailed description

Postpartum pain is a common problem that leads to difficulties in basic daily activities, overuse of opioid medications, and even impaired breastfeeding ability. Non-opioid analgesia may play an essential role in reducing pain and improving the postpartum period including the ability to breastfeed and caring for the newborn. This study will compare non-opioid treatment - 1000 mg Paracetamol versus 400 mg Ibuprofen in order to determine the optimal pain relief treatment in the early postpartum period that may decrease the use of opioid analgesia. The investigators will evaluate the pain by the Numerical Rating Scale (NRS) index in the early postpartum period. The evaluation will conduct at 4-time points - while the women taking the pain relief (time 0), an hour later (time 1), 4, and 6 hours later (time 4 and time 6). The investigators will compare the analgetic effect of each drug and evaluate the need for additional analgesia whether opioid or not. Furthermore, the investigators will examine when women sought pain relief and whether pain relief contributes to the ability of Breastfeeding.

Conditions

Interventions

TypeNameDescription
DRUGParacetamol 1000 mgWomen participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg
DRUGIbuprofen 400 mgWomen participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg

Timeline

Start date
2020-11-28
Primary completion
2022-07-01
Completion
2023-07-06
First posted
2020-12-04
Last updated
2024-02-20

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04653506. Inclusion in this directory is not an endorsement.